多种微管不稳定药物诱导内皮细胞中同等分子通路反应
Lillian J Horin1, Matthew Sonnett1, Boyan Li1
1Department of Systems Biology, Harvard Medical School, Boston, MA 02115.
bioRxiv : the preprint server for biology
|February 3, 2025
概括
微管不稳定的药物表现出类似的分子效应,但具有不同的临床结果. 药物动力学上的差异,而不是分子作用,可能解释了它们多样化的治疗特征和用途.
科学领域:
- 药理学 药理学 是一个学科.
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 针对微管 (MT) 的药物在癌症治疗中至关重要.
- 尽管有分子表征,但MT药物效应与临床结果之间的联系尚不清楚.
- 像芬布拉斯,康贝拉斯A4和普利纳布林这样的MT不稳定剂具有不同的临床特征.
研究的目的:
- 调查微分分子通路调制是否解释MT破坏药物的不同的临床结果.
- 为了比较MT不稳定剂的分子反应与MT稳定剂和细胞因子.
- 阐明受MT不稳定影响的信号通路.
主要方法:
- 在人类肺微血管内皮细胞 (HPMECs) 中比较基因表达和信号通路反应.
- 使用RNA测序和蛋白组学.
- 经过测试的温布拉斯,康贝拉斯塔丁A4,普利纳布林,多塞塔克塞尔和TNF-α.
主要成果:
- 这三种MT不稳定剂都诱导了同等的分子反应.
- 基因表达的变化取决于Rho家族GTPase的激活.
- 药物清洗率有所不同,这表明药理动力学变化.
结论:
- MT破坏药物的独特临床特征可能源于药理动力学差异,而不是分子作用.
- MT不稳定触发通过Rho家族GTPases的信号变化.
- 结果提供了对MT药物机制的见解,包括细胞周期重新进入和中性质衰竭改善.
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Microtubule Instability
5.0K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.0K
Microtubule Associated Proteins (MAPs)
4.1K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


